============================================================
Terminal Output Log - 2026-01-28
Agent: GLM-4.7-test-openrouter-10dollar-1
============================================================


============================================================
ğŸ“… LiveBench Daily Session: 2026-01-28
   Agent: GLM-4.7-test-openrouter-10dollar-1
============================================================

âœ… Task state updated: 74d6e8b0-f334-4e7e-af55-c095d5d4d1a6

ğŸ”„ Iteration 1/15
ğŸ’­ Agent: I'll analyze my situation and decide on today's activity.

**My Current Situation:**
- Balance: $120.50 (stable but not comfortable)
- Token costs so far: $0.50 (minimal)
- Available funds: Adequate f...
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: decide_activity
   ğŸ“¥ Args: {'activity': 'work', 'reasoning': 'I need to increase my financial stability from $120.50. This task...
   âœ… Result: {'success': True, 'activity': 'work', 'reasoning': 'I need to increase my financial stability from $120.50. This task pays up to $50 and involves creating menopause hormone therapy guidelines, which builds valuable healthcare knowledge for future work while providing immediate income. With 15 iterations available, I have ample time to conduct thorough research and create a comprehensive Word document with citations.', 'message': 'âœ… Decision made: WORK'}

ğŸ”„ Iteration 2/15
ğŸ’­ Agent: I'll now work on creating comprehensive hormone therapy prescribing guidelines for MenoHelp. Let me start by researching current evidence-based guidelines from professional societies and medical liter...
ğŸ”§ Tool calls: 3

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'NAMS menopause hormone therapy guidelines 2023 2024 prescribing recommendations', 'max_re...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'NAMS menopause hormone therapy guidelines 2023 2024 prescribing recommendations', 'answer': 'NAMS recommends hormone therapy for menopause symptoms but also highlights nonhormone options like weight loss and testosterone for sexual desire. The 2023 guidelines emphasize individualized treatment plans. Current recommendations focus on evidence-based, nonhormonal therapies.', 'results_count': 5, 'results': [{'url': 'https://www.healio.com/news/womens-health-ob-gyn/20230607/nams-releases-recommendations-to-treat-menopause-symptoms-with-nonhormone-therapies', 'title': 'NAMS releases recommendations to treat menopause symptoms ...', 'content': '* The Nonhormone Therapy Position Statement provides evidence-based recommendations for treating menopause symptoms. â€œMany women cannot or prefer not to take hormone therapy for hot flashes, but they are often unsure of what nonhormone options work and what doesnâ€™t,â€ **Chrisandra** **L.** **Shufelt,** ... (truncated)

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'International Menopause Society hormone therapy guidelines 2023', 'max_results': 5}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'International Menopause Society hormone therapy guidelines 2023', 'answer': 'The 2023 International Menopause Society guidelines recommend hormone therapy for menopausal symptoms, emphasizing individualized treatment plans and considering risks like thrombosis. Hormone therapy remains effective for vasomotor symptoms if started within 10 years of menopause. Updated guidelines are available on the IMS website.', 'results_count': 5, 'results': [{'url': 'https://www.imsociety.org/2023/12/22/december-2023/', 'title': 'December 2023 - International Menopause Society', 'content': 'Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients. Eur J Haematol. 2023;111(5):678-686. Background Estrogen-', 'score': 0.99996233, 'raw_content': None}, {'url': 'https://www.imsociety.org/statements/ims-recommendations/', 'title': 'IMS Recommendations - International Menopause Society', 'content': 'View recommendations of the Internati... (truncated)

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'ACOG hormone therapy menopause practice bulletin recommendations', 'max_results': 5}...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'ACOG hormone therapy menopause practice bulletin recommendations', 'answer': 'Systemic hormone therapy is the most effective treatment for menopause-related symptoms. Estrogen alone or with progestin is recommended. Nonhormonal options should be considered for women with hormone-sensitive breast cancer.', 'results_count': 5, 'results': [{'url': 'https://journals.lww.com/greenjournal/fulltext/2014/01000/practice_bulletin_no__141__management_of.37.aspx', 'title': 'Practice Bulletin No. 141: Management of Menopausal Symptoms', 'content': 'Systemic hormone therapy (HT), with estrogen alone or in combination with progestin, is the most effective therapy for vasomotor symptoms related to menopause.', 'score': 0.9998416, 'raw_content': None}, {'url': 'https://www.acog.org/womens-health/faqs/hormone-therapy-for-menopause', 'title': 'Hormone Therapy for Menopause - ACOG', 'content': '# Hormone Therapy for Menopause. * Hormone therapy is a medica... (truncated)

ğŸ”„ Iteration 3/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy estrogen dosing guidelines contraindications prescribing', 'max...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy estrogen dosing guidelines contraindications prescribing', 'answer': 'Estrogen therapy is typically prescribed at the lowest effective dose for less than 5 years. Contraindications include breast cancer, cardiovascular disease, and smoking. Patient selection focuses on those under 60 with low risks.', 'results_count': 5, 'results': [{'url': 'https://hospitalhandbook.ucsf.edu/11-menopause-hrt/11-menopause-hrt', 'title': '11. Menopause & HRT - UCSF Hospitalist Handbook', 'content': 'Some guidelines recommend treatment for <5 years for combined menopausal hormone therapy and <7 years for estrogen therapy. In general, prescribe lowest dose', 'score': 0.9998623, 'raw_content': None}, {'url': 'https://home.hippoed.com/blog/the-beginners-guide-to-menopausal-hormone-therapy-mht', 'title': 'The Beginners Guide to Menopausal Hormone Therapy (MHT)', 'content': 'Menopausal hormone therapy (MHT) is having a moment, and pati... (truncated)

ğŸ”„ Iteration 4/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy oral transdermal estrogen progesterone formulations monitoring'...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy oral transdermal estrogen progesterone formulations monitoring', 'answer': 'Transdermal estrogen is preferred over oral hormone therapy for women at moderate cardiovascular risk. Micronized progesterone is commonly used. Monitoring is essential due to potential health risks.', 'results_count': 5, 'results': [{'url': 'https://www.canadianmenopausesociety.org/sites/default/files/pdf/publications/Final-Pocket%20Guide.pdf', 'title': 'POCKET GUIDE MENOPAUSE MANAGEMENT', 'content': 'Women at moderate risk of cardiovascular events, if offered MHT, should preferentially use transdermal estrogen rather than oral. Use of micronized progesterone', 'score': 0.6688159, 'raw_content': None}, {'url': 'https://www.cda-amc.ca/sites/default/files/pdf/htis/2025/RD0073-MHT_Rapid_Review-final.pdf', 'title': 'Comparative Evidence Between Transdermal and Oral ...', 'content': '............................................................ (truncated)

ğŸ”„ Iteration 5/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'vaginal estrogen therapy menopause genitourinary syndrome of menopause GSM treatment', 'm...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'vaginal estrogen therapy menopause genitourinary syndrome of menopause GSM treatment', 'answer': 'Vaginal estrogen therapy is an effective treatment for genitourinary syndrome of menopause (GSM). It has minimal side effects and does not increase cancer or cardiovascular disease risk. Low-dose vaginal estrogen is recommended for moderate-to-severe GSM symptoms.', 'results_count': 5, 'results': [{'url': 'https://thischangedmypractice.com/genitourinary-syndrome-of-menopause/', 'title': 'Genitourinary syndrome of menopause (GSM) â€” a refresher', 'content': 'Vaginal estrogen preparations are an effective treatment for GSM for many women. These include vaginal estrogen creams, suppositories, tablets,', 'score': 0.8793233, 'raw_content': None}, {'url': 'https://www.rachelrubinmd.com/gsm', 'title': 'Genitourinary Syndrome of Menopause (GSM) - Rachel Rubin, MD', 'content': "Local vaginal hormone therapy is a critical preventative treatment and ca... (truncated)

ğŸ”„ Iteration 6/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy risks benefits venous thromboembolism stroke breast cancer card...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy risks benefits venous thromboembolism stroke breast cancer cardiovascular', 'answer': 'Menopausal hormone therapy can reduce menopausal symptoms but increases risks of stroke, venous thromboembolism, and breast cancer. Cardiovascular benefits are not well-established. Consult a healthcare provider for personalized advice.', 'results_count': 5, 'results': [{'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC9178928/', 'title': 'Menopausal Hormone Replacement Therapy and Reduction of All ...', 'content': 'Magnitude and type of HRT-associated risks, including breast cancer, stroke and venous thromboembolism are rare (<10 events/10,000 women), not unique to HRT and', 'score': 0.7813477, 'raw_content': None}, {'url': 'https://www.uptodate.com/contents/menopausal-hormone-therapy-benefits-and-risks', 'title': 'Menopausal hormone therapy: Benefits and risks - UpToDate', 'content': 'Menopausal hormone therapy: Benefits an... (truncated)

ğŸ”„ Iteration 7/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy contraindications absolute relative patient selection screening...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy contraindications absolute relative patient selection screening', 'answer': 'Absolute contraindications to menopause hormone therapy include hormone-dependent cancers and active cardiovascular disease. Relative contraindications involve conditions like breast cancer, endometrial cancer, and thromboembolic disorders. Screening is essential for patient selection.', 'results_count': 5, 'results': [{'url': 'https://academic.oup.com/jcem/article/100/11/3975/2836060', 'title': 'Treatment of Symptoms of the Menopause: An Endocrine Society ...', 'content': 'There are no commonly recognized lists of absolute or relative contraindications to MHT as published in professional society guidelines. And whereas US', 'score': 0.99990904, 'raw_content': None}, {'url': 'https://emedicine.medscape.com/article/276104-overview', 'title': 'Menopausal Hormone Therapy: Overview, Symptoms and Effects of ...', 'content': 'No absolute con... (truncated)

ğŸ”„ Iteration 8/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy dosing guidelines oral estradiol transdermal estradiol microniz...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy dosing guidelines oral estradiol transdermal estradiol micronized progesterone', 'answer': 'Oral estradiol typically starts at 0.5-1 mg daily, and micronized progesterone is 100-200 mg for 12-14 days monthly. The maximum transdermal estradiol dose is 100 mcg/24 hours.', 'results_count': 5, 'results': [{'url': 'https://onlinelibrary.wiley.com/doi/10.1111/cen.15211', 'title': 'Update on Menopause Hormone Therapy; Current Indications and ...', 'content': 'Continuous oral or transdermal estrogen;. Estradiol tablets 1 mg/2 mg. Estradiol patch doses range from 25 Î¼g to 100 Î¼g/', 'score': 0.9998859, 'raw_content': None}, {'url': 'https://vajenda.substack.com/p/getting-started-on-menopause-hormone', 'title': 'Getting Started on Menopause Hormone Therapy - The Vajenda', 'content': 'Oral estradiol 0.5 mg-1 mg a day and, for those with a uterus, oral progesterone 100 mg a day or 200 mg for 12-14 days a month. Oral', 'scor... (truncated)

ğŸ”„ Iteration 9/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'telemedicine virtual menopause care hormone therapy evaluation low moderate risk patients...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'telemedicine virtual menopause care hormone therapy evaluation low moderate risk patients', 'answer': 'Telemedicine offers virtual menopause care with hormone therapy for low to moderate risk patients. Services are available nationwide and often covered by insurance. Doctors provide personalized treatment plans and monitor symptoms.', 'results_count': 5, 'results': [{'url': 'https://atriumhealth.org/medical-services/prevention-wellness/womens-health/virtual-menopause-care', 'title': "Virtual Menopause Care | Women's Care - Atrium Health", 'content': '# Virtual Menopause Care. With virtual menopause care, Atrium Health Womenâ€™s Care makes it easy to get the guidance you need, from anywhere. And with us, virtual menopause care is more than convenient â€“ itâ€™s clinically excellent, too. Atrium Health Womenâ€™s Care takes a holistic, evidence-based approach to managing menopause â€“ all through the convenience of a video visit. Virtual menopause c... (truncated)

ğŸ”„ Iteration 10/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy initial evaluation laboratory testing blood work physical asses...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy initial evaluation laboratory testing blood work physical assessment', 'answer': 'Initial evaluation for menopause hormone therapy includes a physical assessment and blood tests for hormone levels, thyroid function, and complete blood count. Lab tests are generally not required to start HRT but may be needed if symptoms are unclear or other conditions are suspected.', 'results_count': 5, 'results': [{'url': 'https://emedicine.medscape.com/article/264088-workup', 'title': 'Menopause Workup: Laboratory Studies, Endometrial Assessment', 'content': "2. Santoro N, Randolph JF Jr. Reproductive hormones and the menopause transition. Update on menopausal hormone therapy. [Guideline] â€œThe 2022 Hormone Therapy Position Statement of The North American Menopause Societyâ€ Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Safety of Vaginal Estrogen Therapy for Genitourinary ... (truncated)

ğŸ”„ Iteration 11/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'menopause hormone therapy follow-up monitoring annual evaluation symptoms management when...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'menopause hormone therapy follow-up monitoring annual evaluation symptoms management when to discontinue', 'answer': 'Annual follow-up is recommended for menopause hormone therapy. Discontinue when benefits no longer outweigh risks or after age 65. MHT is most effective for vasomotor symptoms.', 'results_count': 5, 'results': [{'url': 'https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061559', 'title': 'Rethinking Menopausal Hormone Therapy: For Whom, What, When ...', 'content': 'However, age alone should not dictate when HT is discontinued. ... Among women who initiated systemic HT within 10 years of menopause onset,', 'score': 0.9991704, 'raw_content': None}, {'url': 'https://academic.oup.com/jcem/article/100/11/3975/2836060', 'title': 'Treatment of Symptoms of the Menopause: An Endocrine Society ...', 'content': 'Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the... (truncated)

ğŸ”„ Iteration 12/15
âš ï¸ Attempt 1 failed (TimeoutError), retrying in 0.5s...
   Error: API call timed out after 60.0 seconds
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': '"North American Menopause Society" "hormone therapy position statement" 2022 2023', 'max_...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'North American Menopause Society hormone therapy position statement 2022 2023', 'answer': 'The 2022 NAMS hormone therapy position statement recommends hormone therapy for most healthy symptomatic women under 60 and within 10 years of menopause, emphasizing its benefits outweigh risks. It suggests hormone therapy can be used until the mean age of menopause unless contraindicated. Low-dose vaginal estrogen is recommended for genitourinary symptoms alone.', 'results_count': 3, 'results': [{'url': 'https://ce.mayo.edu/sites/default/files/media/2023-05/2022NAMSPositionStatement.pdf', 'title': '2022 NAMS Hormone Therapy Position Statement:', 'content': 'Low dose hormonal therapies are safe and effective. â€¢ No progestogen is needed. â€¢ Use low dose vaginal estrogen when. GSM is the only menopause symptom.', 'score': 0.9999738, 'raw_content': None}, {'url': 'https://www.letstalkmenopause.org/our-articles/nams-2022-hormone-therapy-position-statem... (truncated)

ğŸ”„ Iteration 13/15
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: read_webpage
   ğŸ“¥ Args: {'urls': 'https://ce.mayo.edu/sites/default/files/media/2023-05/2022NAMSPositionStatement.pdf'}...
   âœ… Result: {'success': True, 'provider': 'tavily_extract', 'urls': 'https://ce.mayo.edu/sites/default/files/media/2023-05/2022NAMSPositionStatement.pdf', 'results': [], 'failed_results': [{'url': 'https://ce.mayo.edu/sites/default/files/media/2023-05/2022NAMSPositionStatement.pdf', 'error': 'Failed to fetch url'}], 'results_count': 0, 'response_time': 0.22, 'usage': {}, 'message': 'âœ… Extracted content from 0 URL(s)', 'api_cost': '$0.000160', 'cost_type': 'flat_rate'}

ğŸ”„ Iteration 14/15
âš ï¸ Attempt 1 failed (TimeoutError), retrying in 0.5s...
   Error: API call timed out after 60.0 seconds
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'FDA approved menopause hormone therapy products estradiol progesterone medications list',...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'FDA approved menopause hormone therapy products estradiol progesterone medications list', 'answer': 'FDA-approved menopause hormone therapies include estradiol (Estrace, Climara) and progesterone (Prometrium). Combinations like estradiol with micronized progesterone are also approved. Always consult a healthcare provider for specific treatment options.', 'results_count': 5, 'results': [{'url': 'https://www.goodrx.com/conditions/menopause/bioidentical-hormone-therapy?srsltid=AfmBOoqrPa0HyUrNtA0dTymx7NMzr-JrdyNokkrfwgFPanHL0i1MD9tn', 'title': 'Bioidentical Hormone Therapy: Types, Uses, and Cost - GoodRx', 'content': 'There are FDA-approved bioidentical hormone products available, including those containing estradiol (Estrace, Climara, Vivelle) and progesterone (Prometrium).', 'score': 0.9999621, 'raw_content': None}, {'url': 'https://www.fda.gov/files/for%20consumers/published/Menopause-Medicines-To-Help-You.pdf', 'title': '[PDF] Menopaus... (truncated)

ğŸ”„ Iteration 15/15
âš ï¸ Attempt 1 failed (TimeoutError), retrying in 0.5s...
   Error: API call timed out after 60.0 seconds
ğŸ’­ Agent: 
ğŸ”§ Tool calls: 1

   ğŸ“ Calling: search_web
   ğŸ“¥ Args: {'query': 'premature ovarian insufficiency early menopause hormone therapy guidelines surgical menop...
   âœ… Result: {'success': True, 'provider': 'tavily', 'query': 'premature ovarian insufficiency early menopause hormone therapy guidelines surgical menopause', 'answer': 'Premature ovarian insufficiency is managed with hormone replacement therapy until natural menopause age. Surgical menopause guidelines are similar, but hormone therapy is recommended until age 50-51. Early menopause guidelines may apply to POI cases.', 'results_count': 5, 'results': [{'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC11631070/', 'title': 'Evidence-based guideline: premature ovarian insufficiency', 'content': 'by N Panay Â· 2024 Â· Cited by 173 â€” In this guideline, cessation of ovarian function in women aged from 40 and <45 (age 40â€“44 years) will be termed early menopause.', 'score': 0.99997115, 'raw_content': None}, {'url': 'https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Premature-ovarian-insufficiency', 'title': 'Guideline on premature ovarian insufficiency', 'content': "ESHRE Â® uses cookies to improve your bro... (truncated)

âš ï¸ Iteration limit reached without task completion
ğŸ”„ Initiating wrap-up workflow to collect artifacts...

============================================================
ğŸ”„ WRAP-UP WORKFLOW: Collecting and submitting artifacts
============================================================
ğŸ” Listing artifacts in E2B sandbox...
   ğŸ“¦ Connected to sandbox: None
   ğŸ” Scanning directory: /tmp
      Found 4 items in /tmp
   ğŸ” Scanning directory: /home/user
      Found 4 items in /home/user
   ğŸ” Scanning directory: /home/user/artifacts
      âš ï¸ Could not list /home/user/artifacts: path not found: lstat /home/user/artifacts: no such file or directory
   âš ï¸ No artifacts found in any directory
      Scanned: /tmp, /home/user, /home/user/artifacts
   No artifacts found to submit

============================================================
âœ… WRAP-UP WORKFLOW COMPLETE
============================================================


âš ï¸ Wrap-up workflow did not submit any work
ğŸ§¹ Cleaned up task sandbox
